Investor Presentation - First Nine Months of 2016 slide image

Investor Presentation - First Nine Months of 2016

Investor presentation First nine months of 2016 Slide 52 GLP-1 effect dependent on level of blood glucose - which reduces risk of hypoglycaemia GLP-1 mechanism of action when blood sugar levels increase • Increases insulin secretion in the pancreas Reduces glucagon secretion in the liver • Slows gastric emptying in the gut . Creates sense of satiety in the brain Brain GLP-1 lowers blood glucose in patients with type 2 diabetes Type 2 diabetes patients, no GLP-1 Type 2 diabetes patients, with GLP-1 Healthy controls receiving saline Glucose (mmol/L) 18 16 14 12 10 8 6 changing diabetes GLP-1 Liver Gut Pancreas 642O Breakfast Lunch Snack 22.00 02.00 06.00 10.00 T 14.00 18.00 Time Source: Rachman et al. Diabetologia 1997;40:205-11 novo nordisk
View entire presentation